Posts Tagged ‘tramadol’
Labopharm Reports Results For Phase III Study On Twice-daily Tramadol-acetaminophen Formulation
Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) announced the results of its recently completed North American Phase III clinical trial for its twice-daily formulation of tramadol and acetaminophen (study 06CCL3-001). Study 06CCL3-001 was a multi-centre, randomized, double-blind, parallel-arm study that compared the efficacy and safety of Labopharm’s twice-daily tramadol-acetaminophen formulation to placebo in the treatment of moderate to severe acute low back pain.
Popular Painkiller Tramadol Added To Kentucky Prescription Drug Monitoring System
The Cabinet for Health and Family Services Office of Inspector General (OIG) is increasing efforts to monitor the types and amounts of potentially addictive prescription drugs dispensed to Kentuckians, recently becoming only the second state to add the drug Tramadol to its list of controlled substances. Tramadol, which is intended to alleviate pain, has been added by the OIG to a list of pharmaceutical products falling under the category of “schedule IV” narcotics.
Rx Drug Compare
Translator
By N2H